Screening
-
Targeted substances
- Triglyceride
- Bilirubin
- Carbamazepine
- Digoxin
- Methotrexate
- Bile acid
- Paraquat
- Myoglobin
- Cholesterol
- Inflammatory Mediators and Cytokines
- Leptin
- Ammonia
- Protein-bound toxins
- β2-MG
- Organophosphate
- PTH
- Rivaroxaban
- 2,4-Dinitrophenol
- Ticagrelor
- Paracetamol
- Metformin
- ANA and ds-DNA Titers
- Abrin
- Sodium Valproate
- Amlodipine
- Estazolam
- Quetiapine
- Olanzapine
- Ziprasidone
- Vancomycin
- Organophosphorus
- Circulating Bacteria
- Liver Enzymes(e.g. ALT,AST)
- Vancomycin
- Gentamicin
- Poison
- Protein Binded Substance
- Antimicrobials
- Plasma-free hemoglobin(PfHb)
- Uremic Toxins
- Amylase
- Creatine Kinase(CK)
- C-Reactive Protein(CRP)
- Others
- Antithrombotics
- Calcium Channel Blocker (Amlodipine)
- Lactate
- Ammonia
-
Benefits
- Improve QOL
- Decrease Vasopressor Needs
- Stabilize Hemodynamics
- Improve Oxygenation
- Bridge to Liver Transplantation
- Reduce the Incidence of Adverse Effect
- Shorten ICU Stay
- Reduce Bleeding Complications
- Reduce Mechanical Ventilation
- Improve Respiratory Function
- Lower the Mortality Rate
- Improve Liver Function
- Improve Sleep Efficiency
- Improve HE
- Improve Renal Function
- Relieve Uremic Pruritis
- Reduce Cardiovascular Related Events
- Improve Survival Rate
- Remove Inflammatory Markers/ Cytokines
- Reduce Circulating Bacterial Load
- Improve Disease Symptoms
- Improve Laboratory Parameters
- Cost Effectiveness
- Others
- Disease
- Endocarditis
- Poisoning/Drug Overdose
- Leptospirosis
- Sepsis/ Septic Shock
- Multiple Myeloma
- Severe Acute Pancreatitis(SAP)
- Multiple Organ Dysfunction Syndrome(MODS)
- Rhabdomyolysis
- Dengue
- Leukemia-Sepsis
- Burn
- Trauma
- Open Heart Surgery
- Acute Respiratory Distress Syndrome (ARDS)
- Hepatic Encephalopathy(HE)
- End Stage Renal Disease(ESRD)
- Acute Kidney Injury(AKI)
- Systemic Lupus Erythematosus (SLE)
- Liver Transplantation
- Liver Failure(LF)
- Jaudice
- Subarachnoid Hemorrhage
- Symmetrical Peripheral Gangrene(SPG)
- Wasp Stings
- Acute Renal Failure
- Hepatitis
- Cardiopulmonary Bypass(CPB)
- Severe Liver Injury
- Henoch-Schönlein Purpura (HSP)
- COVID-19
- Polymyositis
- Liver Cirrhosis
- Hyperbilirubinemia
- Maintenance Hemodialysis (MHD)
- Crush Syndrome
- Human Immunodeficiency Virus(HIV)
- Immunological Diseases (IMD)
- Hyperlipidemia
- Infection
- Others
- Acute Type A Aortic Dissection (ATAAD)
- Autoimmune Hepatitis (AIH)
- Chronic Hepatitis C (HCV)
- Cancer-Related Complications
- Cardiogenic Shock
-
Efficacy of CA330 hemoadsorption combined with CRRT in sepsis-associated acute kidney injury: A retrospective cohort study
Du, Qian. [J] Medicine 105(5):p e47487, January 30, 2026. | DOI: 10.1097/MD.0000000000047487
-
Hemoadsorption in Cardiac Surgery for Inflammation Control: Case Report
Reis B B, Peixoto R, Batista J C. [J]. Revista Científica Hospital Santa Izabel, 2025, 9(2): 109-113.
-
Immature Granulocyte Trajectories Following Hemadsorption as Indicators of Immune Dysregulation and Mortality
Altuntaş G, Çapar A, Özçelik G, et al. [J]. Journal of Clinical Medicine, 2026, 15(3): 1011.
-
Role of Hemoperfusion With HA330 in the Management of Severe Dengue Shock Syndrome
Virojtriratana T, Nan K N, Samransamruajkit R. [J]. Journal of Tropical Medicine, 2026, 2026(1): 9928338.
-
Clinical Efficacy of a Protocol-based Hemoadsorption Therapy in Patients with Septic Shock
Gül F, Tekin E, Çankaya E, et al. [J]. Turkish Journal of Intensive Care, 2025: 1-15.
-
Extracorporeal hemoperfusion as an adjunctive therapy for liver failure
Shafigh N, Jafari A, Alipour H, et al. [J]. Journal of Artificial Organs, 2026, 29(1): 14.
-
Double plasma molecular adsorption system combined with plasma exchange successfully treated thyroid storm and severe liver injury A case report
Liu J, Zhang W. [J]. Medicine, 2025, 104(51): e46686.
-
Effects of different therapeutic methods on the 90-day prognosis of patients with HBV-ACLF: A systematic review and network meta-analysis
Hua Y, Liu H, He Y, et al. [J]. Medicine, 2025, 104(51): e46388.
-
Effect and prognostic factors of the double plasma molecular adsorption system combined with partial plasma exchange (DPMAS-PPE) in patients with liver failure
Liu X, Zhao X, Liang C, et al. [J]. Clinical and Experimental Hepatology, 11(4): 387-399.
-
Guidelines for the diagnosis and treatment of acute-on-chronic liver failure (2025)
Chen Y, Han T, Duan Z, et al. [J]. Chinese Medical Journal, 2025, 138(24): 3218-3221.
-
Efficacy of DPMAS combined with PE in improving survival outcomes of patients with acute hepatitis E-induced liver failure: A retrospective cohort analysis
Tang R, Ji Y, Yao H, et al. [J]. iLIVER, 2025: 100203.
-
Effects of combined haemodialysishaemoadsorption therapy in maintenance haemodialysis patients: study protocol for a multicentre, openlabel, randomised, parallel controlled trial
Huang W, Zhang L, Wu H, et al. [J]. BMJ open, 2025, 15(11): e107017.
-
Hemoadsorption in Postoperative Heart Transplant Patients or Cardiogenic Shock Patients on VA-ECMO
Angie Giselle Otalvaro-Pechene, Edgardo Quiñones, et al. [J]. Salutem Scientia Spiritus, 2025.
-
Prognostic value of inflammatory cytokine levels, clinical efficacy, and prognosis of the hybrid artificial liver support system in chronic liver failure treatment
Liu L, Li X, Wang J, et al. [J]. Journal of Medical Biochemistry, 2025, 44(7): 1429.
-
Enhanced cognitive outcomes with triple-mode dialysis in kidney failure: role of protein-bound toxin clearance
Wang M, Hua W, Chen L, et al. [J]. Renal Failure, 2025, 47(1): 2590874.
-
Effect of extracorporeal membrane oxygenation combined with hemoperfusion on inflammatory factors in patients with cardiogenic shock
Hao JY, Wang SF, Yang Q, et al. World J Cardiol. 2025;17(8):109903. doi:10.4330/wjc.v17.i8.109903
-
Hemoadsorption contribution in neonatal cardiac surgery
Molinari I, Aidala E, Cascarano MT, et al. Front Cardiovasc Med. 2025;12:1615697. Published 2025 Sep 17. doi:10.3389/fcvm.2025.1615697
-
Effectiveness of haemodialysis with hemoperfusion therapeutic modality in paediatric chronic kidney disease
Widiasta A, Rossanti R, Rachmadi D, Hilmanto D.. Med Glas (Zenica). 2025 Aug 25;22(2):304-310. doi: 10.17392/1906-22-02. PMID: 41082758.
-
Clinical Experience of Combining Single-Use HA130 Hemoadsorption Cartridge with High-Flux Hemodialysis in Maintenance Hemodialysis Patients
L.A. Fedotova, N.V. Shchekotikhina, M.A. Ershova, E.I. Gryaznova. 43rd Vicenza Course AKICRRT-EBPT and Critical Care Nephrology,2025
-
Extracorporeal hemoadsorption and neurological disorders: A challenging perspective
J Transl Crit Care Med 2025;7:e25-00015


